Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
Abstract Purpose TP53 mutation, one of the most frequent mutations in early‐stage lung adenocarcinoma (LUAD), triggers a series of alterations in the immune landscape, progression, and clinical outcome of early‐stage LUAD. Our study was designed to unravel the effects of TP53 mutation on the immunop...
Main Authors: | Chengde Wu, Xiang Rao, Wei Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3655 |
Similar Items
-
Construction and Validation of an Immune-Related Prognostic Model Based on TP53 Status in Colorectal Cancer
by: Xiaojuan Zhao, et al.
Published: (2019-11-01) -
Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
by: Hao Sun, et al.
Published: (2020-10-01) -
STRAP as a New Therapeutic Target for Poor Prognosis of Pancreatic Ductal Adenocarcinoma Patients Mainly Caused by TP53 Mutation
by: Shanshan Hu, et al.
Published: (2020-09-01) -
Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
by: Xinqing Lin, et al.
Published: (2020-11-01) -
Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
by: Chunyu Zhang, et al.
Published: (2021-09-01)